Cargando…

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs

We investigated the impact of pathologic differentiation (well or poorly differentiated) in metastatic grade 3 GEP-NEC patients receiving etoposide and platinum (EP)-based therapy, and evaluated a more exact Ki67 index cut-off point to select patients with grade 3 GEP-NEC who might benefit from EP-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hee Kyung, Ha, Sang Yun, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Park, Young Suk, Kim, Seung Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650316/ https://www.ncbi.nlm.nih.gov/pubmed/29088761 http://dx.doi.org/10.18632/oncotarget.18168

Ejemplares similares

Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
por: Kim, Seung Tae, et al.
Publicado: (2016)

The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
por: Kim, Seung Tae, et al.
Publicado: (2016)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
por: Park, Seongyeol, et al.
Publicado: (2016)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas
por: Menger, Richard, et al.
Publicado: (2017)

Malignant Pleural Mesothelioma—Does Ki67 Make the Grade?
por: Prall, Owen W.J.
Publicado: (2021)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Ki-67 labeling index as a prognostic marker in advanced stomach cancer
por: Seo, Sang Hyuk, et al.
Publicado: (2019)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker?
por: Baig Mirza, Asfand, et al.
Publicado: (2021)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma
por: Xu, Guangda, et al.
Publicado: (2021)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

NEC 2015
por: Collective
Publicado: (2015)

NEC Symposium
por: Kamimura, Hiroshi, et al.
Publicado: (1989)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
por: Kim, Bohyun, et al.
Publicado: (2019)

Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of cell differentiation()
por: Bonhin, Rodrigo Gonzalez, et al.
Publicado: (2014)

HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides
por: Kim, Geehyuk, et al.
Publicado: (2019)

Synaptophysin-Ki67 Double Stain: A Novel Technique That Improves Interobserver Agreement in the Grading of Well-Differentiated Gastrointestinal Neuroendocrine Tumors
por: Matsukuma, Karen, et al.
Publicado: (2017)

Ki-67 immunostaining in astrocytomas: Association with histopathological grade – A South Indian study
por: Shivaprasad, Nandish Vastrad, et al.
Publicado: (2016)

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
por: Wang, Hai-Yue, et al.
Publicado: (2019)

Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
por: Theresia, Emilia, et al.
Publicado: (2020)

Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades
por: Simbolo, Michele, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
por: Kim, Seung Tae, et al.
Publicado: (2017)

Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
por: Kim, Hyung Sun, et al.
Publicado: (2016)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

HOXC6 Overexpression Is Associated With Ki-67 Expression and Poor Survival in NPC Patients
por: Chang, Shih-Lun, et al.
Publicado: (2017)

Evaluation of Caspase-3 and Ki-67 expression in squamous cell hyperplasia of the stomach induced by Platycodi radix water extract in Sprague–Dawley rats
por: Li, Yinghua, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index
por: Lee, Janghee, et al.
Publicado: (2020)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022)

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
por: Jung, Ki Sun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0g4r75s93f1ee62s6hohbrrrpi